https://doi.org/10.1016/j.redox.2017.05.012
C
Carmelo Millón
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
65
Papers
993
Citations
18
h-index
26
i10-index
Carmelo Millón is an academic researcher from Instituto de Investigación Biomédica de Málaga. The author has contributed to research in topics: Neuropeptides and Animal Physiology & Receptor Mechanisms and Signaling & Cardiovascular, Neuropeptides, and Oxidative Stress Research. The author has an h-index of 18, co-authored 56 publications.
ORCID: 0000-0001-7580-5506Papers by this author
worksIGF-II promotes neuroprotection and neuroplasticity recovery in a long-lasting model of oxidative damage induced by glucocorticoids
2017 · Redox Biology · 79 citations
Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease
2021 · Redox Biology · 58 citations
https://doi.org/10.1016/j.redox.2021.102095
A new pharmacological strategy against treatment-resistant depression
2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 3 citations
https://doi.org/10.1016/j.pnpbp.2024.111191
A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)
2024 · Current Neuropharmacology · 0 citations
https://doi.org/10.2174/1570159x23666241003125019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat